High risk of systemic lupus erythematosus development in patients with ITP: antiphospholipid syndrome is also a concern
- PMID: 32826277
- DOI: 10.1136/annrheumdis-2020-218345
High risk of systemic lupus erythematosus development in patients with ITP: antiphospholipid syndrome is also a concern
Keywords: antiphospholipid syndrome; autoimmunity; lupus erythematosus, systemic.
Conflict of interest statement
Competing interests: None declared.
Comment in
-
Response to: 'High risk of systemic lupus erythematosus development in patients with ITP: antiphospholipid syndrome is also a concern?' by Inanc et al.Ann Rheum Dis. 2022 Jul;81(7):e111. doi: 10.1136/annrheumdis-2020-218402. Epub 2020 Sep 28. Ann Rheum Dis. 2022. PMID: 32988836 No abstract available.
Comment on
-
Risk of systemic lupus erythematosus in patients with idiopathic thrombocytopenic purpura: a population-based cohort study.Ann Rheum Dis. 2020 Jun;79(6):793-799. doi: 10.1136/annrheumdis-2020-217013. Epub 2020 Apr 2. Ann Rheum Dis. 2020. PMID: 32241798
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
